Neurogene NGNE
NASDAQ NGNE
$24.64 -1.44 (-5.52%)
As of: Oct 22, 2026 · 1:17 PM EDT

Neurogene (NGNE) Asset Utilization Ratio (2016 - 2025)

Updated

Neurogene's Asset Utilization Ratio came in at 0.00 for Q2 2025, down 38.8% from 0.00 a year earlier.

Analysis

Neurogene (NGNE) Asset Utilization Ratio (2016 - 2025) Analysis & Trends

Going back to Q3 2019, Neurogene's Asset Utilization Ratio data covers 8 quarters.

  • The Q2 2025 figure represents the lowest quarterly Asset Utilization Ratio in data going back to Q3 2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Eli Lilly 1,165.98 Bn 1,134.57 Bn 19.71 Bn 0.62
2 Johnson & Johnson 643.66 Bn 563.53 Bn 17.30 Bn 0.50
3 AbbVie 500.95 Bn 474.06 Bn 12.70 Bn 0.47
4 Merck 358.08 Bn 312.45 Bn 12.21 Bn 0.52
5 Novartis Ag 301.84 Bn 265.83 Bn 11.24 Bn 0.46
6 Astrazeneca 267.25 Bn 240.94 Bn 12.86 Bn 0.51
7 Amgen 241.42 Bn 196.81 Bn 7.24 Bn 0.40
8 Gilead Sciences 193.09 Bn 167.28 Bn 6.22 Bn 0.58
9 Pfizer 171.63 Bn 118.27 Bn 10.94 Bn 0.31
10 Neurogene 552.86 Mn -450.13 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 0.00
Dec 31, 2024 0.00
Sep 30, 2024 0.01
Jun 30, 2024 0.00
Dec 31, 2023 0.01
Sep 30, 2023 0.02
Jun 30, 2023 0.02
Mar 31, 2023 0.02
Dec 31, 2022 0.01
Sep 30, 2022 0.01
Jun 30, 2022 0.00
Mar 31, 2022 6.40
Dec 31, 2021 5.90
Sep 30, 2021 5.51
Sep 30, 2019 14.28
Dec 31, 2018 0.30
Sep 30, 2018 0.26
Jun 30, 2018 0.25
Sep 30, 2016 0.00
Jun 30, 2016 0.00
API Access

Neurogene Asset Utilization Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=NGNE&period=max&api_key=YOUR_API_KEY